TLSA•benzinga•
Tiziana Developing Intranasal Foralumab Therapy And Enters Into Product Development Agreement With Renaissance To Optimize Formulation And Scale-Up Foralumab For Treating Neurodegenerative And Inflammatory Diseases
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 21, 2025 by benzinga